J. Tovey

Role of transforming growth factor Beta in corneal function, biology and pathology.

A. Tandon, J. Tovey, A. Sharma, 2010, Current molecular medicine.

Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

David J. Robertson, J. D. Robertson, Alexander M Klibanov, 2011, Nanomedicine : nanotechnology, biology, and medicine.

Decorin biology, expression, function and therapy in the cornea.

A. Tandon, J. Tovey, A. Sharma, 2011, Current molecular medicine.

AAV serotype influences gene transfer in corneal stroma in vivo.

J. Tovey, R. Mohan, Arkasubhra Ghosh, 2010, Experimental eye research.

Targeted Decorin Gene Therapy Delivered with Adeno-Associated Virus Effectively Retards Corneal Neovascularization In Vivo

J. Tovey, R. Mohan, Ajay Sharma, 2011, PloS one.

Gene therapy in the Cornea: 2005–present

J. Tovey, R. Mohan, Ajay Sharma, 2012, Progress in Retinal and Eye Research.

Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.

J. Tovey, R. Mohan, Ajay Sharma, 2011, Investigative ophthalmology & visual science.

Vorinostat: a potent agent to prevent and treat laser-induced corneal haze.

J. Tovey, R. Mohan, Ajay Sharma, 2012, Journal of refractive surgery.

Murine T cells reactive to type II collagen. II. Functional characterization.

J. Tovey, J. Chiller, J. Stuart, 1986, Journal of immunology.

Efficacious and Safe Tissue-Selective Controlled Gene Therapy Approaches for the Cornea

J. Tovey, R. Mohan, Ajay Sharma, 2011, PloS one.